Bafna Pharmaceuticals has informed that meeting of board of directors of the Company is scheduled to be held on Monday, February 12, 2024, to consider and approve the Un-Audited Standalone Financial Results of the Company for the third quarter of FY24 ended December 31, 2023, together with the 'Limited Review Report' for the said period.
The above information is a part of company’s filings submitted to BSE.